Bedford, MA, United States of America

Patricia Greenhaigh

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi Pasteur Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patricia Greenhaigh. Retrieved from https://idiyas.com/inventor/patricia-greenhaigh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Patricia Greenhaigh

Introduction

Patricia Greenhaigh is an accomplished inventor based in Bedford, MA (US). She has made significant contributions to the field of cancer treatment through her innovative work. Her dedication to research and development has led to the creation of a valuable patent that addresses critical health challenges.

Latest Patents

Patricia holds 1 patent for her invention titled "Modified CEA/B7 vector." This invention relates to a nucleic acid encoding a polypeptide and its application in preventing and treating cancer. Specifically, it focuses on improved vectors for the insertion and expression of foreign genes encoding tumor antigens, which are essential for immunotherapeutic treatment of cancer.

Career Highlights

Patricia is currently employed at Sanofi Pasteur Inc., where she continues to advance her research in the field of immunotherapy. Her work is pivotal in developing new strategies for cancer treatment, showcasing her commitment to improving patient outcomes.

Collaborations

Throughout her career, Patricia has collaborated with notable colleagues, including Mark Parrington and Linong Zhang. These partnerships have enhanced her research efforts and contributed to the success of her projects.

Conclusion

Patricia Greenhaigh's innovative contributions to cancer treatment through her patented work exemplify her dedication to advancing medical science. Her efforts continue to inspire and pave the way for future breakthroughs in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…